LCI699, a potent 11?-hydroxylase inhibitor, normalizes urinary cortisol in patients with Cushing's disease: results from a multicenter, proof-of-concept study / Bertagna, X; Pivonello, Rosario; Fleseriu, M; Zhang, Y; Robinson, P; Taylor, A; Watson, Ce; Maldonado, M; Hamrahian, Ah; Boscaro, M; Biller, Bm. - In: THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM. - ISSN 0021-972X. - 99:(2014). [10.1210/jc.2013-2117]
LCI699, a potent 11?-hydroxylase inhibitor, normalizes urinary cortisol in patients with Cushing's disease: results from a multicenter, proof-of-concept study.
PIVONELLO, ROSARIO;
2014
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
